Immune response to hepatitis B vaccine among health-care worker in Sebha

Main Article Content

Ebtesam Mohammed Al-Shukri
Hussein Ahmed Al-Rasheed
Adel Mohammed Al-Shukri

Abstract

Hepatitis is a global health problem and the most common occupational risk among health-care workers, as they are at greater risk of infection, occupational exposure occurs when injected, contaminated needles are used, or directly when dealing with patients, as well as during the potentially contagious blood transfusion or blood products. The purpose of this study is to assess the immune response to the hepatitis virus vaccine among healthy personnel in the city of Sebha after receiving the vaccine. Blood samples were collected for anti-surface antibodies test ,A sample of 102 persons was taken (79.4%) for females, 21 (20.6%) for males. The results of the screening of anti-surface antibodies showed that 86.3% were positive, while 13.7% were negative after receiving the vaccine. From this study, we conclude that the vaccine response was effective at 86.3%, while a significant percentage of  13.7% did not show a response, and they need to be  revaccinated or given a booster dose, Regarding the impact of gender on the  immune response .statistical results indicated no significant differences between males and females. It was  found that the lowest positive response rate was among those who received only one dose of the series, while the highest rate was in the group that received three doses. There were no significant differences between the number of doses and the positive samples, while the negative samples showed statistical significance with a p-value of 0.04. Therefore, we recommend completing the vaccination series for healthcare workers and monitoring their immune response by measuring the concentration of antibodies to the surface antigen.  

Article Details

How to Cite
Al-Shukri ا., Al-Rasheed ح. ا., & Al-Shukri ع. م. (2024). Immune response to hepatitis B vaccine among health-care worker in Sebha. Sebha University Conference Proceedings, 3(2), 522–527. https://doi.org/10.51984/sucp.v3i2.3419
Section
Confrence Proceeding

References

A. Elbahrawy et al., "Recent advances in protective vaccines against hepatitis viruses: A narrative review," Viruses, vol. 15, no. 1, p. 214, 2023.

S. Tsukuda and K. Watashi, "Hepatitis B virus biology and life cycle," Antiviral research, vol. 182, p. 104925, 2020.

A. Madhavan, D. S. Palappallil, J. Balakrishnapanicker, and A. Asokan, "Immune response to hepatitis B vaccine: An evaluation," Perspectives in Clinical Research, vol. 12, no. 4, pp. 209-215, 2021.

ا. و. خدام, "الاستجابة المناعية تجاه لقاح التهاب الكبد B لدى الأطفال المصابين بالداء السكري من النمط الأول," مجلة جامعة البعث-سلسلة العلوم الطبية والصحية, vol. 43, no. 25, 2021.

I. A. Mwangi et al., "Assessment of hepatitis B vaccination status and hepatitis B surface antibody titres among health care workers in selected public health hospitals in Kenya," PLOS Global Public Health, vol. 3, no. 4, p. e0001741, 2023.

J. Pattyn, G. Hendrickx, A. Vorsters, and P. Van Damme, "Hepatitis B vaccines," The Journal of infectious diseases, vol. 224, no. Supplement_4, pp. S343-S351, 2021.

R. F. Wassouf and Y. A. Zreik, "Evaluation of hepatitis B virus antibodies in serum in vaccinated children at Tishreen University Hospital in Syria," مجلة العلوم الطبية و الصيدلانية, vol. 6, no. 5, pp. 88-94, 2022.

ع. ا. ع. حسين and أ. د. خ. ح. نوري, "الخطر المدرك لالتهاب الكبد الفيروسي B لدى الممرضين والممرضات," مجلة المستنصرية للعلوم والتربية, vol. 22, no. 2, pp. 279-296, 2021.

A. E. Mahgoub, Y. Hamadalnil, O. Mohammed, R. Nakhleh, and M. M. Khair, "A cross-sectional study on Hepatitis B immune status among vaccinated healthcare workers in Khartoum, Sudan," Sudan Journal of Medical Sciences, vol. 15, no. 1, pp. 35–42-35–42, 2020.

M. Ocan, F. Acheng, C. Otike, J. Beinomugisha, D. Katete, and C. Obua, "Antibody levels and protection after Hepatitis B vaccine in adult vaccinated healthcare workers in northern Uganda," Plos one, vol. 17, no. 1, p. e0262126, 2022.

W. H. Gerlich, "Medical virology of hepatitis B: how it began and where we are now," Virology journal, vol. 10, pp. 1-25, 2013.

J. K.-T. Ho, B. Jeevan-Raj, and H.-J. Netter, "Hepatitis B virus (HBV) subviral particles as protective vaccines and vaccine platforms," Viruses, vol. 12, no. 2, p. 126, 2020.

A. Trevisan et al., "Future healthcare workers and hepatitis B vaccination: a new generation," International Journal of Environmental Research and Public Health, vol. 18, no. 15, p. 7783, 2021.

M. M. Mashraqi-E-mail and S. A. Alshamrani, "Persistence of hepatitis B surface antibody to hepatitis B vaccine among medical college students in Najran University, Saudi Arabia," Bioinformation, vol. 18, no. 7, pp. 617-621, 2022.

D. Obiri-Yeboah et al., "Post Hepatitis B vaccination sero-conversion among health care workers in the Cape Coast Metropolis of Ghana," PloS one, vol. 14, no. 6, p. e0219148, 2019.

S. H. Ali, B. A. Rasheed, and T. S. Al-Hadithi, "Protective hepatitis B surface antibody (Anti-HBs) levels among health care workers in Duhok city of Iraq," Turkish Journal of Public Health, vol. 16, no. 2, pp. 79-89, 2018.